Literature DB >> 9271341

Enhanced apoptosis in metallothionein null cells.

Y Kondo1, J M Rusnak, D G Hoyt, C E Settineri, B R Pitt, J S Lazo.   

Abstract

Metallothioneins (MTs) are major intracellular, zinc-binding proteins with antioxidant properties. Mouse embryonic cells null for MT due to loss of functional MT I and II genes (MT-/-) were more susceptible to apoptotic death after exposure to tert-butyl hydroperoxide or the anti-cancer agents cytosine arabinoside, bleomycin, melphalan, and cis-dichlorodiammineplatinum(II) compared with wild-type mouse embryonic cells (MT+/+). We measured basal levels of the tumor suppressor protein p53 and the death effector protein Bax and found the basal levels of both proteins were higher in MT null cells compared with MT+/+ cells. After treatment with the DNA-damaging agent cis-dichlorodiammineplatinum(II), p53 protein levels were induced in both MT+/+ and MT-/- cells with MT null cells always maintaining the highest p53 levels. The elevated sensitivity to apoptosis was not restricted to embryonic cells. Primary pulmonary fibroblasts were isolated from distinct litters of MT null, heterozygous, and wild-type mice, and all had undetectable basal MT levels. Zinc exposure increased MT levels in the wild-type and heterozygous fibroblasts but not in the MT null fibroblasts. Consistent with the induced MT levels, we found MT+/+ and MT+/- embryonic cells were less sensitive to cis-dichlorodiammineplatinum(II)-induced apoptosis compared with MT-/- cells. Our results implicate MT as a stress-responsive factor that can regulate apoptotic engagement.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271341     DOI: 10.1124/mol.52.2.195

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  25 in total

1.  Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein.

Authors:  L L Pearce; R E Gandley; W Han; K Wasserloos; M Stitt; A J Kanai; M K McLaughlin; B R Pitt; E S Levitan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  CNS wound healing is severely depressed in metallothionein I- and II-deficient mice.

Authors:  M Penkowa; J Carrasco; M Giralt; T Moos; J Hidalgo
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

3.  Transcriptomic analyses in a benthic fish exposed to contaminated estuarine sediments through laboratory and in situ bioassays.

Authors:  Pedro M Costa; Célia Miguel; Sandra Caeiro; Jorge Lobo; Marta Martins; Ana M Ferreira; Miguel Caetano; Carlos Vale; T A DelValls; Maria H Costa
Journal:  Ecotoxicology       Date:  2011-06-10       Impact factor: 2.823

Review 4.  Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy.

Authors:  Hiroshi Okumura; Yasuto Uchikado; Tetsuro Setoyama; Masataka Matsumoto; Tetsuhiro Owaki; Sumiya Ishigami; Shoji Natsugoe
Journal:  Surg Today       Date:  2013-04-19       Impact factor: 2.549

5.  Influenza virus infection induces metallothionein gene expression in the mouse liver and lung by overlapping but distinct molecular mechanisms.

Authors:  K Ghoshal; S Majumder; Q Zhu; J Hunzeker; J Datta; M Shah; J F Sheridan; S T Jacob
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

6.  Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels.

Authors:  Stephanie Schäfer; Frank-Gerald Pajonk; Gerd Multhaup; Thomas A Bayer
Journal:  J Mol Med (Berl)       Date:  2007-01-09       Impact factor: 4.599

7.  SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents.

Authors:  H Duan; Y Wang; M Aviram; M Swaroop; J A Loo; J Bian; Y Tian; T Mueller; C L Bisgaier; Y Sun
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

8.  The evaluation of metallothionein expression in nasal polyps with respect to immune cell presence and activity.

Authors:  Magdalena Dutsch-Wicherek; Romana Tomaszewska; Agata Lazar; Paweł Strek; Łukasz Wicherek; Krzysztof Piekutowski; Wojciech Jóźwicki
Journal:  BMC Immunol       Date:  2010-03-09       Impact factor: 3.615

9.  Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study.

Authors:  Per Boye Hansen; Milena Penkowa
Journal:  Support Care Cancer       Date:  2016-12-13       Impact factor: 3.603

10.  The Balance between Life and Death of Cells: Roles of Metallothioneins.

Authors:  Allan Evald Nielsen; Adam Bohr; Milena Penkowa
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.